Healthcare -
Biotechnology - NASDAQ - US
$ 0.1538
-1.91 %
$ 6.11 M
Market Cap
-0.14
P/E
VIRX - CASH & EQUIVALENTS
Cash & Equivalents VIRX - Viracta Therapeutics, Inc.
12.3 M
LAST VALUE
-65.51%
2 YEAR CAGR
-2.10%
5 YEAR CAGR
-2.03%
10 YEAR CAGR